ArticleCalcified tissue international1984
Serum vitamin D metabolites in younger and elderly postmenopausal women.
Article in Calcified tissue international, 1984. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.Drugs & aging · 1994Trial
- Decrease in bone level of 1,25-dihydroxyvitamin D in women over 45 years old.Calcified tissue international · 1992Article
- Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.Calcified tissue international · 1990Article
- Parathyroid hormone, 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentration in elderly patients.Klinische Wochenschrift · 1990Article
- Serum concentration of vitamin D metabolites in rheumatoid arthritis.Clinical rheumatology · 1987Article
- Osteoporosis, calcium and physical activity.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 1987Review
- The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis.Calcified tissue international · 1986Article
- Risk factors for osteoporosis and associated fractures.Public health reports (Washington, D.C. : 1974)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Previous investigations have suggested that a lower-than-normal serum 1,25(OH)2D is found in elderly women with postmenopausal osteoporosis. We examined the fundamental aspects of this theory by investigating serum vitamin D metabolites in four representative samples of Caucasian women. These included 44 early postmenopausal women divided into two subgroups: fast bone losers, that is, bone loss greater than 3%/year (n = 20), and "physiological" bone loss (n = 24); and 28 70-year-old women divided into two subgroups: with and without osteoporotic fractures. Serum 1,25(OH)2D concentrations were virtually the same in all groups thus contradicting the previous reports of low 1,25(OH)2D in elderly women. Furthermore, mean 25OHD and 24,25(OH)2D did not differ between the groups. We conclude that 1,25(OH)2D is unlikely to be significant in the development or treatment of a majority of women with postmenopausal osteoporosis.
Indexed as
Identifiers
6423232What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.